AptarGroup, Inc. designs and manufactures a range of drug delivery, consumer product dispensing, and active material science solutions and services for the pharmaceutical, beauty, personal care, home care, and food and beverage markets. The company operates through Aptar Pharma, Aptar Beauty, and Aptar Closures segments. It also provides pumps for nasal allergy treatments; and metered dose inhaler valves for respiratory ailments, such as asthma and chronic obstructive pulmonary diseases; elastomer for injectable primary packaging components; and active material science solutions. In addition, the company offers dispensing pumps, closures, elastomeric components, aerosol valves, and digital health solutions. It primarily sells its products and services in Asia, Europe, Latin America, and North America. AptarGroup, Inc. was incorporated in 1992 and is headquartered in Crystal Lake, Illinois.

AptarGroup Inc.

Piper Sandler Sticks to Their Buy Rating for Atricure (ATRC)

Astron Limited ( ($AU:ATR) ) just unveiled an announcement. Astron Limited’s Donald Project Joint Venture has signed a Journey and Understanding Ag...

Astron’s Donald Project Seals Indigenous Partnership for Wimmera Mineral Sands Development

In a report released yesterday, from CICC initiated coverage with a Buy rating on Caterpillar and a price target of $800.00. In addition to CICC, C...

Caterpillar (CAT) Has a New Rating from CICC

Stifel Nicolaus analyst Ian Gillies maintained a Buy rating on AtkinsRealis today and set a price target of C$121.00. According to TipRanks, Gillie...

Stifel Nicolaus Keeps Their Buy Rating on AtkinsRealis (SNCAF)

There’s a lot to be optimistic about in the Industrial Goods sector as 3 analysts just weighed in on Astronics (ATRO – Research Report), ITT (ITT –...

Analysts Offer Insights on Industrial Goods Companies: Astronics (ATRO), ITT (ITT) and Bowman Consulting Group (BWMN)

William Blair analyst Matt Larew assigned a Hold rating to the stock yesterday. The company’s shares closed yesterday at $123.98. According to TipR...

William Blair Releases a Hold Rating on AptarGroup (ATR)

Mizuho Securities analyst maintained a Hold rating on Yamato Holdings Co today and set a price target of Yen2,100.00. In a report released yesterda...

Mizuho Securities Remains a Hold on Yamato Holdings Co (YATRF)

Goldman Sachs analyst maintained a Hold rating on Yamato Holdings Co today and set a price target of Yen1,850.00. In a report released yesterday, T...

Goldman Sachs Keeps Their Hold Rating on Yamato Holdings Co (YATRF)

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Atricure (ATRC – Research Report), Wave Life Science...

Analysts Offer Insights on Healthcare Companies: Atricure (ATRC), Wave Life Sciences (WVE) and Arcellx Inc (ACLX)

Astron Limited ( ($AU:ATR) ) has issued an update. Astron Limited reported significant progress at its Donald Rare Earth and Mineral Sands Project ...

Astron Advances Donald Rare Earth Project with Major Project Status and Funding Progress

Astron Limited ( ($AU:ATR) ) has shared an announcement. Astron Limited reported a net operating cash outflow of A$1.18 million for the quarter end...

Astron Boosts Cash Reserves via Asset Sales Despite Operating Outflows

Morgan Stanley analyst Angel Castillo maintained a Sell rating on Caterpillar today and set a price target of $400.00. Castillo covers the Industri...

Morgan Stanley Sticks to Its Sell Rating for Caterpillar (CAT)

Yamato Holdings Co ( ($JP:9064) ) has issued an update. Yamato Holdings has announced a major reshuffle of its top management, with current Represe...

Yamato Holdings to Appoint TA-Q-BIN Chief Sakurai as New President in 2026 Leadership Overhaul

Kepler Capital analyst Julian Megias maintained a Buy rating on Atrys Health SA on January 16 and set a price target of €5.00. The company’s shares...

Atrys Health SA (A2T) Gets a Buy from Kepler Capital

Astron Limited ( ($AU:ATR) ) has issued an update. Astron Limited has responded to an ASX query regarding delayed lodgement of Change of Director’s...

Astron Moves to Tighten Compliance After Administrative Lapse on Director Interest Notices

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Atricure (ATRC – Research Report) and Boston Scienti...

Analysts Offer Insights on Healthcare Companies: Atricure (ATRC) and Boston Scientific (BSX)

An update from Atara Biotherapeutics ( ($ATRA) ) is now available. On January 12, 2026, Atara Biotherapeutics reported that the U.S. Food and Drug ...

	A	B	C	D
1	Symbol	Price	Change	Volume
2	ATR	$139.58	-0.42%	270.12K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	ATR	$139.58	-0.4%	270.12K
3
4
5
6

ATR

ATR

Get AptarGroup Inc. Data in Excel

Get AptarGroup Inc. Data in Excel